SINGLE VENTRICLE HEART DISEASE
Clinical trials for SINGLE VENTRICLE HEART DISEASE explained in plain language.
Never miss a new study
Get alerted when new SINGLE VENTRICLE HEART DISEASE trials appear
Sign up with your email to follow new studies for SINGLE VENTRICLE HEART DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could boost exercise for teens with half a heart
Disease control Recruiting nowThis study tests whether a daily pill called udenafil can improve exercise ability in teenagers who had the Fontan procedure for single-ventricle heart disease. About 436 teens aged 12 to 18 will take either the drug or a placebo for 26 weeks. The main goal is to see if their pea…
Matched conditions: SINGLE VENTRICLE HEART DISEASE
Phase: PHASE3 • Sponsor: Mezzion Pharma Co. Ltd • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
Could a diabetes pill ease pressure in failing fontan hearts?
Symptom relief Recruiting nowThis study tests whether the drug dapagliflozin, taken for 3 months, can lower vein pressure in adults with a surgically repaired single ventricle heart (Fontan circulation). About 27 participants will receive either the drug or a placebo. The goal is to see if the drug helps the…
Matched conditions: SINGLE VENTRICLE HEART DISEASE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 17, 2026 07:00 UTC